GENZYME CORP Excess Tax Benefit from Share-based Compensation, Operating Activities
GENZYME CORP reported Excess Tax Benefit from Share-based Compensation, Operating Activities of -$19.80 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities · last filed 2011-03-01
- GENZYME CORP excess tax benefit from share-based compensation, operating activities for the quarter ending 2010-12-31 was -$4.31M.
- GENZYME CORP excess tax benefit from share-based compensation, operating activities for the quarter ending 2010-09-30 was -$10.11M.
- GENZYME CORP excess tax benefit from share-based compensation, operating activities for the quarter ending 2010-06-30 was -$4.89M, a 624.89% decline year-over-year.
- GENZYME CORP excess tax benefit from share-based compensation, operating activities for the quarter ending 2010-03-31 was -$480.00K, a 113.75% decline year-over-year.
- GENZYME CORP excess tax benefit from share-based compensation, operating activities for fiscal 2010 was -$19.80M, a 698.94% decline from fiscal 2009.
- GENZYME CORP excess tax benefit from share-based compensation, operating activities for fiscal 2009 was $3.31M, a 82.08% decline from fiscal 2008.
- GENZYME CORP excess tax benefit from share-based compensation, operating activities for fiscal 2008 was $18.45M.
| Period end | Excess Tax Benefit from Share-based Compensation, Operating Activities 3 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 6 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 9 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 12 month |
|---|---|---|---|---|
| 2010-12-31 | -$4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | -$14.42M derived: sum of 2 quarters · filed 2011-03-01 | -$19.32M derived: sum of 3 quarters · filed 2011-03-01 | -$19.80M 10-K · filed 2011-03-01 |
| 2010-09-30 | -$10.11M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09 | -$15.00M derived: sum of 2 quarters · filed 2010-11-09 | -$15.48M 10-Q · filed 2010-11-09 | -$15.48M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-06-30 | -$4.89M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2010-09-07 | -$5.37M 10-Q/A · filed 2010-09-07 | -$5.38M derived: sum of 3 quarters · filed 2011-03-01 | -$6.49M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-03-31 | -$480.00K 10-Q/A · filed 2010-05-11 | -$484.00K derived: sum of 2 quarters · filed 2011-03-01 | -$1.60M derived: sum of 3 quarters · filed 2011-03-01 | -$667.00K derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | -$1.12M derived: sum of 2 quarters · filed 2011-03-01 | -$187.00K derived: sum of 3 quarters · filed 2011-03-01 | $3.31M 10-K · filed 2011-03-01 |
| 2009-09-30 | -$1.11M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09 | -$183.00K derived: sum of 2 quarters · filed 2010-11-09 | $3.31M 10-Q · filed 2010-11-09 | $4.28M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-06-30 | $932.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2010-09-07 | $4.42M 10-Q/A · filed 2010-09-07 | $5.40M derived: sum of 3 quarters · filed 2011-03-01 | $14.22M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-03-31 | $3.49M 10-Q/A · filed 2010-05-11 | $4.47M derived: sum of 2 quarters · filed 2011-03-01 | $13.29M derived: sum of 3 quarters · filed 2011-03-01 | |
| 2008-12-31 | $975.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $9.80M derived: sum of 2 quarters · filed 2011-03-01 | $18.45M 10-K · filed 2011-03-01 | |
| 2008-09-30 | $8.82M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2009-11-02 | $17.47M 10-Q · filed 2009-11-02 | ||
| 2008-06-30 | $8.65M 10-Q/A · filed 2009-09-04 | |||
| 2007-12-31 | $13.57M 8-K · filed 2010-06-14 |